Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of inhaled LASAG plus standard of care versus placebo in hospitalized adults with serious influenza
2012-004072-19Phase 2Terminated
- Sponsor
- Vectura
- Start
- Oct 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of l-asparaginase + azaribine + prednisone + azathioprine + 6-thioguanine in influenza, Influenza A infection, influenza B, sponsored by Vectura. Started Oct 2012; status: terminated.
02
Drugs
l-asparaginase + azaribine + prednisone + azathioprine + 6-thioguanine
03
Conditions
influenzaInfluenza A infectioninfluenza B
Beyond the preview
Go deeper on 2012-004072-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004072-19.